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Introduction: Electronic prescribing (ePrescribing)
systems are rapidly being introduced into National
Health Systems (NHS) hospitals in England following
their widespread earlier adoption into primary care
settings. Such systems require substantial changes in
the way pharmacists organise their work and perform
their roles. There is however as yet limited evidence on
the extent to which these changes may support or
compromise efficient and safe working practices by
pharmacists. Identifying and quantifying these
changes, and their effects, is central to informing
system and work practice design, as well as informing
training and implementation processes. This protocol
describes a study to measure the impact of
ePrescribing systems on pharmacists’ time and
workflow.
Methods and analysis: A direct observational
controlled pre–post implementation time-and-motion
study will be conducted in six wards at one NHS Trust
over two observational periods. Pharmacists will be
shadowed and details of all work tasks performed will
be collected and time-stamped. Task distribution,
frequency and duration will be measured and changes
in these measures preimplementation and
postimplementation, and between control and
intervention wards will be measured. Interviews with
pharmacists will investigate their perceptions of the
impact of the ePrescribing systems on their work and
will be conducted in both periods. The extent to which
pharmacists’ expectations of the impact of the
ePrescribing systems on their work with
postimplementation reports will be qualitatively
explored, as will any differences between perceptions
and results from the time-and-motion analysis.
Ethics and dissemination: Institutional research
ethics approval has been obtained from The University
of Edinburgh. Local approval from the participating
NHS Trust and informed consent from participating
pharmacists have been obtained, while also complying
with local governance requirements. The results of the
study will be presented at conferences, published in
peer-reviewed journals, and shared with members of
our Patient and Public Involvement Group, to facilitate
wider dissemination.
INTRODUCTION
Electronic prescribing (ePrescribing) systems
are now well established in UK primary
care,1 2 but widespread adoption of fully
computerised prescribing systems has to date
only been achieved in a few UK hospitals.3
The National Health Service (NHS)
Connecting for Health has deﬁned
ePrescribing as: “The utilisation of electronic
systems to facilitate and enhance the commu-
nication of a prescription or medicine order,
aiding the choice, administration and supply
of a medicine through knowledge and deci-
sion support and providing a robust audit
trail for the entire medicines use process.”
The adpotion of an ePrescribing system is a
disruptive innovation that can lead to major
workﬂow changes that are expected to result
in a range of beneﬁts, including time savings
for professionals. However, existing evidence
of work efﬁciency beneﬁts of ePrescribing
when compared to paper-based systems is
mixed and differs depending on the health
professional groups studied.4–14 Studies indi-
cate prescribers spend less time calculating
drug dosages and looking for paper charts,4 5
and a reduction of pharmacist time spent
ﬁlling prescriptions and prescription monitor-
ing.6 7 However, other evidence indicates that
ePrescribing can make some tasks more time-
consuming for certain healthcare profes-
sionals.5 8–14 For example, research has shown
increases in time spent on order entry for pre-
scribers.8 9 There is also evidence that medi-
cines administration may become more
time-consuming.15
In light of this mixed evidence base, and
the fact that most of the previous work has
focused on doctors using bespoke and exten-
sively customised ePrescribing systems in
North American settings,5 7–11 we seek to
investigate the impact of ePrescribing systems
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on pharmacists’ time and workﬂows in hospitals in
England. This work is important, as investments in and
implementation of such systems tend to be based on
(among other things) assumptions surrounding time-
savings for individual users.5 16 This may in turn lead to
inﬂated expectations among users. Concerns regarding
changes in work practices has been identiﬁed as the
central concern of both clinicians and managers in rela-
tion to the introduction of ePrescribing in hospitals.17 If
workﬂows are disrupted in unexpected ways, increases in
workloads and increased time required for certain tasks
not anticipated and planned for in advance, then adop-
tion and user satisfaction will be negatively affected.18
More realistic expectations are also likely to facilitate
training approaches, increase acceptance of systems by
healthcare professionals and decrease the risk that the
technology is rejected or used in ways other than
intended.19–21 Pharmacists have been the least studied
healthcare professional group in this respect yet the
implementation of such electronic systems require sub-
stantial changes in the way hospital pharmacists organise
their work and perform their role.
As part of a national programme of research being
undertaken to inform deliberations on the safe, effective
and efﬁcient procurement and implementation of
ePrescribing systems into NHS hospitals in England,22
we are planning to undertake a rigorous quantitative
assessment of the impact of commercially available
ePrescribing systems implemented in two English NHS
hospitals on pharmacists’ time and workﬂows and simul-
taneously qualitatively study pharmacists perceptions and
experiences of this transition to ePrescribing.
STUDY AIMS AND OBJECTIVES
The overall aim is to assess the impact of commercially
available ePrescribing systems implemented in two hospi-
tals, in one English NHS Trust, on pharmacists’ time
and workﬂows.
Our objectives are to measure time spent undertaking
medication related tasks, clinical and non-clinical tasks
and communication patterns before and following the
implementation of an ePrescribing system at the study
hospital sites, and to understand pharmacists’ percep-
tions and experiences of this move to ePrescribing
systems.
STUDY DESIGN
A direct observational time-and-motion study will be
conducted using a controlled before-and-after design
with contemporaneous controls. This will take place in a
total of six wards at two hospitals in one English NHS
Trust over two observational periods. In the intervention
wards, observations will be made both before and after
the implementation of the ePrescribing system, with con-
temporaneous observations in the control wards. The
participating hospitals will select the study wards based
on local plans to implement ePrescribing systems. The
intervention wards will not have the ePrescribing system
implemented until the end of the ﬁrst observation
period. The control wards will not have the ePrescribing
system implemented at any time during the observation
periods.
To explore the perceptions of pharmacists of the
impact of the system on time and workﬂows, we will
conduct interviews with the pharmacists participating in
the time-and-motion study both before and after the
implementation of ePrescribing.
OUTCOME MEASURES
The primary outcome will be changes (before and after,
and between intervention and control groups) in the
proportions of time spent on each particular group of
tasks as a percentage of the overall time observed. The
group of tasks of interest are:
▸ Time spent with patients.
▸ Time spent on clinical activities.
Secondary outcomes will include the distribution of
the numbers and durations of tasks within each group
of tasks.
The tasks observed are presented in online supple-
mentary appendix I.
STUDY SETTING
The two hospitals from which the wards will be selected
are ready to implement ePrescribing and have a local
requirement for an impact assessment of the new
ePrescribing system. In each hospital data will be col-
lected in three wards with similar patient proﬁles. Two
of these wards (one in each hospital) are scheduled to
implement the ePrescribing system between the two data
collection points. The four remaining wards will func-
tion as controls. In these, implementation is scheduled
to occur after the conclusion of the study.
We aim to observe individual pharmacists during their
working day in comparable wards with relatively high
rates of medication-related activity, in order to produce
comparable results and capture a range of relevant tasks.
PARTICIPANT SELECTION AND ENROLMENT
The aim is to observe pharmacists working on each of
the control and intervention wards in each hospital. All
pharmacists at the participating hospitals, on duty on
the wards being observed at the time of the observa-
tions, will be invited and will be asked to provide written
informed consent to participate. Pharmacists will be
invited to participate with the help of relevant pharmacy
managers.
At the time of recruitment, pharmacists will also be
invited to participate in short semistructured interviews
focusing on exploring their perceptions on the impact
of ePrescribing on their work. We acknowledge, that the
availability of pharmacists at the time of the work will
depend on local workloads and stafﬁng levels.
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ETHICS, GOVERNANCE AND CONSENT
Observations will not include recording of any patient-
related data. The research team will supply an informa-
tion sheet to each participating pharmacist on invitation
to participate in observations/interviews. Written
consent to take part in observations/interviews will be
sought, comprising a signed consent form signed by
both researcher and participant. All participants will be
encouraged to discuss any questions with the research
team prior to data collection. All ﬁeldwork will be
undertaken with due regard to maintaining the best
interests of participants.
Pharmacists being observed will be asked to verbally
notify patients to the presence of the researcher observ-
ing the workﬂow of the pharmacist. If a patient objects,
the observer will take a note and cease observations
while the pharmacist attends to that patient. To ensure
that patients who are not able to provide their assent to
the presence of the researcher are not approached,
ward managers will be asked to identify these patients in
advance. These may include people who are not able to
understand the instructions for cognitive or sensory
reasons, or lack of English, or who are too distressed or
ill to be involved, or who are under 16 years of age. The
observer will make a note using a proforma which
records these patients’ bed number (not their name).
This process will be discussed with ward managers prior
to any observations being carried out.
DATA COLLECTION
The Work Observation Method by Activity Timing
(WOMBAT) tool will be used to collect data.23 This
allows a set of study-determined task categories and sub-
categories to be developed. It is based on previous inter-
national work carried out by others and will therefore
allow for future comparison. For this study we will struc-
ture the WOMBAT data collection under four task
dimensions of: (1) What (the task being observed); (2)
Where (the location where the observed task is being
undertaken); (3) With (the person/people with the
pharmacist at the time the observed task is being under-
taken); and (4) How (how the task is being completed,
eg, using a computer). The software also has the cap-
acity to record information about interruptions and mul-
titasking during observations. It will be customised via a
web application for the purposes of the present work,
and will be installed on tablet computers for data collec-
tion by research staff.
Two researchers will be trained to use the tool and
inter-rater reliability testing will be conducted to ensure
consistency in its application between observers. An
initial training period of 4 weeks on all wards at the hos-
pital sites will offer opportunities for reﬁning the task
classiﬁcation and use of the tool by the observers.
A trained observer will follow one pharmacist at a time
and record/time predeﬁned tasks over several weeks at
different times of the day, according to a deﬁned
observational schedule (see below). Each pharmacist will
be observed over a number of 2 h periods. The postim-
plementation data collection will take place approxi-
mately 3–6 months after the implementation of the
ePrescribing system, in order to allow users to get used
to the new system. Wherever possible, the suggested
time-and-motion procedures proposed by Zheng et al24
will be adhered to, to ensure consistency and quality.
Identiﬁcation details of individual participants, wards
and hospitals will be kept conﬁdential and the data will
be transferred via a web application to a statistical
package.
Interviews, guided by topic guides (see online supple-
mentary appendix II), will explore interviewees’ percep-
tions associated with ePrescribing and work tasks. This
will allow comparison of quantitative measurements and
pharmacists’ perceptions. Participants will be asked
broadly similar questions, but the interviews will be tai-
lored to individual’s areas of work and task categories
recorded. It is also likely that the topic guide will con-
tinue to evolve during the course of the study as more
data are gathered. At least 10 interviews will be con-
ducted which should allow for variability of responses
and data saturation (the point at which no new informa-
tion or themes are observed in the data). All interviews
will be digitally recorded, subject to participant consent
and, together with any accompanying ﬁeld notes, profes-
sionally transcribed verbatim. We expect each interview
to last approximately 10–20 min.
OBSERVATION SCHEDULE
Each pre/post observation period will be conducted
over 4 weeks. Observation sessions of individual ward-
based clinical pharmacists will be 2 h long. Two obser-
vers will each perform up to 6 h of observations per day.
The observers will alternate between the wards on a
daily rotation, and will aim to observe pharmacists on all
wards at each hospital on any 1 day. The pharmacists will
be observed during the allocated 2 h period that may
include time on the ward, in the pharmacy department
or dispensary.
SAMPLE SIZE CALCULATIONS
A total of 410 h (=2×205 h) of observations have been
scheduled. This equates to 205 total hours of observa-
tion preimplementation and a further 205 h of observa-
tions postimplementation. Of the total of 410 observable
hours, 130 h will be for observations in the two interven-
tion wards and 280 h in the four control wards. The pre-
cision of the effect estimate will depend on the number
of individual tasks that go to make up the total time
spent on a task group, and on the SD of the length of
an individual task. This means, for example, that greater
statistical power would be generated if the task
group consisted of a large number of short tasks of rela-
tively constant length than if it comprised a smaller
number of tasks of more variable length. In the absence
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of adequate pilot data on the length and variability of
individual tasks, calculations under several different
assumptions are presented in table 1. The detectable
change in the time spent on a particular task varies
with the coefﬁcient of variation (CV) (CV=SD/mean)
of task duration and the number of relevant tasks
per hour.
For example, if the pharmacist performs, on average,
10 tasks per hour in the ‘time spent with patients’ group
of tasks, and these tasks are such that the SD of task dur-
ation=mean task duration (ie, CV=1), then the study is
powered to detect a change of plus or minus 18.8% in
‘time spent with patients’ time as a result of
ePrescribing. These particular assumptions (CV=1, tasks
per hour=10) are consistent with the earlier study of
doctors’ and nurses’ time spent on medication-related
activities, but are not guaranteed to hold here.13
DATA ANALYSIS
For each group of tasks a difference-in-difference
approach will be used. For the main analysis, the effect
of the intervention will be estimated as the difference
between proportions of time spent on speciﬁc task types
before and after implementation in the intervention
wards, net of the difference in proportions observed
over the same period in the control wards. Normal
approximations will be used, with p=0.05 as a threshold
for statistical signiﬁcance. This approach has been used
by Westbrook et al.13
Qualitative data collection and analysis will be itera-
tive, allowing emerging themes to be explored further
and disconﬁrming evidence to be sought. Thematic
analysis will consist of comparing data within indivi-
duals, system functionalities and perspectives. We expect
the coding framework to be based on the interview
topic guide.
Qualitative and quantitative data will be integrated
after each round of data collection (ie, before and after
implementation) in order to explore perceptions of
changes and time with objective measurements. This will
be followed by integrating ﬁndings and exploring
changes to measurements and perceptions before and
after implementation. Two data coders will analyse the
data. Data will be analysed within individual hospital
sites initially, before making comparisons across sites.25
DISCUSSION
In order to assess the impact of commercially available
ePrescribing systems implemented in hospitals on phar-
macists’ time and workﬂows, a direct observational con-
trolled pre–post implementation time and motion
study is being conducted. Additionally pharmacists’
perceptions and experiences of this transition to
ePrescribing are being explored by conducting per-
sonal interviews. The study represents the only time
and motion study of hospital pharmacists with
ePrescribing as the intervention of interest. As such it
provides a useful baseline for future studies. However,
the results will relate to two English NHS Trust poten-
tially limiting generalisability. Additionally pharmacists
observed may have changed their behaviour as a result
of being observed.
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Table 1 Change in task duration (%) detectable with 80%
power, assuming 320 h of observations divided equally




Number of tasks per hour (for given
activity)
5 10 15 20 25 30
0.5 13.3 9.4 7.7 6.6 5.9 5.4
1.0 26.6 18.8 15.3 13.3 11.9 10.9
1.5 39.9 28.1 23.0 19.9 17.8 16.3
2.0 53.2 37.5 30.7 26.6 23.8 21.7
CV, coefficient of variation.
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